News

Pharma update | NPS’s cinacalcet patent held valid by Court of Appeal

EP ‘761, owned by Shire-NPS Pharmaceuticals Inc. (‘NPS’), relates to the API cinacalcet, which is used for the treatment of conditions of impaired regulation of calcium levels in human blood and tissue fluid. The product is marketed under the name Mimpara®. In September 2017, Accord Healthcare Ltd. and Accord Healthcare B.V. (‘Accord’) initiated invalidity proceedings
Read more ›

BarentsKrans advises the directors of Quintes Holding on its sale to private equity investor Aquiline

BarentsKrans has advised the directors (also shareholders) of Quintes Holding B.V. on the sale of the shares in Quintes Holding B.V. to private equity investor Aquiline Capital Partners. Michiel Martin and Thomas van Hövell tot Westervlier were involved in this transaction. Quintes Holding is one of the largest independent insurance brokers in the Netherlands. Since
Read more ›

Dutch courts on the COVID-19 crisis and the doctrines of unforeseen circumstances and force majeure in commercial contracts

1.     Introduction Since the end of April 2020 Dutch courts (all in summary proceedings) have rendered nine decisions that deal with the the influence of the COVID-19 pandemic on commercial contracts under Dutch law. All cases have been published in Dutch, except one case of the Netherlands Commercial Court (NCC) of 29 April 2020, ECLI:NL:RBAMS:2020:2406 that
Read more ›